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An estimated 42% of all newly diagnosed HIV cases in 
Europe in 2013 were transmitted during sex between 
men. This review was performed to identify and 
describe studies evaluating the efficacy and effec-
tiveness of HIV prevention interventions among men 
who have sex with men (MSM), in relation to imple-
mentation data from European settings. A systematic 
search was performed individually for 24 interven-
tions. Data were extracted from studies including 
efficacy or implementation data from European set-
tings, appraised for efficacy, implementation and 
plausibility, and assigned a grade (1-4) according to 
the Highest Attainable Standard of Evidence (HASTE) 
framework. Four interventions (condom use, peer out-
reach, peer-led groups, and using universal coverage 
of antiretroviral treatment and treatment as preven-
tion) were assigned the highest HASTE grade, 1. 
Another four interventions were assigned 2a for prob-
able recommendation, including voluntary counselling 
and testing for HIV, using condom-compatible lubri-
cant, using post-exposure prophylaxis, and individual 
counselling for MSM living with HIV. In addition, seven 
interventions were assigned a grade of 2b, for possi-
ble recommendation. Encouragingly, 15 interventions 
were graded to be strongly, probably or possibly rec-
ommended. In the relatively resource-rich European 
setting, there is an opportunity to provide global lead-
ership with regard to the regional scale-up of compre-
hensive HIV prevention interventions for MSM. 
Introduction
In 2012 the global burden of HIV was estimated to 
include 35.3 million people living with the virus (peo-
ple living with HIV, PLWH). Among adults between the 
ages of 15–49 years old HIV prevalence was estimated 
at 0.8% [1]. Globally there is a declining trend in new 
infections, morbidity and mortality due to HIV/AIDS [2]. 
Improved treatment regimens and access to treatment 
are important factors behind these trends [2].
Gay, bisexual and other men who have sex with men 
(MSM) are disproportionately affected by HIV in every 
setting where data are available [3]. HIV rates reported 
among MSM show an increasing trend, in contrast to 
the declining trends reported in the general popula-
tion [4]. A 2013 systematic review of HIV epidemiology 
in 33 high-income countries where data were available 
estimated a total of 2.3 million PLWH [5] and a male–
female median case ratio of 2.5: 1 [5,6], indicating 
male-predominant epidemics. High-income countries 
where antiretroviral treatment (ART) and prevention 
services are available show increasing trends in HIV 
prevalence among MSM [5,7].
Of the 29,157 persons diagnosed with HIV and reported 
in the European Union/European Economic area (EU/
EEA) in 2013, 42% of cases were estimated to be due to 
sex between men [8]. Since 2006, MSM represent the 
only key population where an increase in HIV diagno-
ses has been observed, with a 33% increase between 
2004 and 2013 in the EU/EEA overall and with increases 
of more than 100% observed in some EU countries 
during the past decade, including Bulgaria, Cyprus, 
Czech Republic, Hungary, Romania, and Slovakia [9]. 
HIV prevalence among MSM was estimated to be at or 
above 5% in 14 of the 26 EU/EEA countries reporting 
national data in 2012 [10].
In accounting for the relatively higher rates of HIV 
among MSM compared with the general population, 
recent epidemic modelling highlights the importance 
of the higher transmissibility of HIV during unpro-
tected anal intercourse (as opposed to vaginal) and the 
importance of insertive/receptive sexual role versatil-
ity among MSM [4,11]. Clusters of HIV transmission 
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indicative of outbreaks within sexual networks of MSM 
may also play an important role in the higher transmis-
sion probability reported [12-14].
The current picture of the HIV epidemic among MSM in 
Europe highlights significant variation between coun-
tries. Biological and behavioural surveillance systems 
vary across European countries, as do the extent of 
sexual health needs assessment, collaborative service 
planning and the availability of acceptable and acces-
sible sexual health services [15]. Prevalence data for 
MSM, a population of unknown size, can be estimated 
in diverse ways and therefore prevalence rates may not 
be fully comparable between countries. Most European 
countries report the number of newly diagnosed cases 
annually [10].
Community, research, medical and public health efforts 
to prevent HIV have existed in Europe for over three 
decades, with European gay community organisations 
at the forefront of peer-led HIV prevention globally. 
However, overall national responses have been inad-
equate to contain HIV epidemics among MSM, with 
continuing high and in some countries increasing HIV 
incidence among MSM [5,16].
HIV prevention interventions for MSM are purposeful 
activities intended to increase the uptake of HIV pre-
cautionary behaviours or to reduce HIV risk behaviours. 
Intervention activities can target MSM directly, they 
can be directed to intermediaries who deliver activities 
to MSM, or they can influence the policy and service 
environment. The effectiveness of HIV prevention inter-
ventions among MSM has been assessed previously, 
most recently by the World Health Organization Global 
Guidelines process in 2010–11 [17]. In order to capture 
more recent data in the rapidly evolving field of HIV 
prevention and to ensure context-specific relevance, 
there was a need to update and extend the previous 
reviews and catalogue the evidence in order to inform 
MSM prevention interventions in Europe [18,19].
The objectives of this review were to identify and 
describe studies evaluating the efficacy, and effec-
tiveness of HIV prevention interventions among MSM 
in relation to implementation data from the European 
setting, and to further appraise the evidence according 
to the Highest Attainable Standard of Evidence (HASTE) 
framework [20]. The review of evidence was performed 
in order to inform the development of guidance by the 
European Centre for Disease Control and Prevention 
(ECDC) to Member States on the commissioning and 
delivery of HIV prevention interventions to MSM in the 
EU/EEA [21].
Methods
In this review the term ‘men who have sex with men’ 
(MSM) refers to the population of men engaged in 
same-sex sexual behaviour, inclusive of sexual identi-
ties (e.g. gay, bisexual, straight, experimenting, etc.) 
Figure
Work process for systematic review of HIV prevention interventions among men who have sex with men within the 
European setting, searches performed December 2012–February 2013
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and sexual desire. The term MSM includes people 
who identify as men, and therefore includes transgen-
der men who have sex with men. Transgender women 
might share some biological risks with MSM such as 
receptive anal intercourse, but recent data shows a 
higher HIV burden in this group, indicating a differ-
ent epidemic scenario [22], and therefore transgender 
women are not included as a sub-group of MSM in this 
review. We use the term MSM in this review recognis-
ing the diversity and heterogeneity of this group but 
also the limitations of this term.
First, we made a comprehensive list of known interven-
tions that address primary HIV transmission among 
MSM, inclusive of biomedical, psychosocial, and pro-
grammatic interventions. The list was developed, 
discussed and agreed by an expert review group and 
included medical, social science and policy experts, 
programme implementers from non-governmental 
organisations and government representatives. The 
group was convened by the ECDC for the development 
of European guidelines on HIV prevention in MSM. A 
systematic review was performed for each intervention 
included (Figure 1).
 
Existing evidence from randomised controlled trials 
(RCTs) evaluating public health interventions with bio-
logical endpoints for MSM populations are limited, 
which highlights the need for strategies additional 
to the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) system when 
performing a review such as this [18,19,23]. The HASTE 
system builds on the GRADE system and was devel-
oped specifically to evaluate evidence regarding HIV/
sexually transmitted infection (STI) interventions 
among most at-risk populations, in particular MSM 
[19]. HASTE takes into account three categories that 
are given equal weight: efficacy data, implementation 
science data and biological and public health plausibil-
ity (Table 1) [19]. Hill’s criteria for causality remain the 
most relevant set of determinants of whether an inter-
vention causes prevention and/or mitigation of disease 
in the HASTE grading system [24].
Implementation data were defined as data reporting on 
availability, acceptability, uptake, feasibility of imple-
mentation, implementation costs, and effectiveness of 
the intervention among MSM in the European setting.
Public health plausibility was defined as the interven-
tion having a likely pathway leading to a decrease in 
HIV incidence. For example, HIV testing itself might not 
lead directly to lower HIV incidence, but it has a cru-
cial role because it is on the pathway to uptake of ART 
for people living with HIV, which does decrease HIV 
onward transmission and HIV-related morbidity and 
mortality.
Search strategies
The Population, Intervention, Comparison, Outcome 
(PICO) model was used to develop inclusion criteria 
and search terms per intervention [25]. The population 
for the intervention was MSM. All types of comparison 
and no comparison were included. Outcomes included 
were biological markers (prevalence and incidence of 
HIV/STIs), self-reported diagnoses of HIV infection 
and self-reported behavioural outcomes on condom 
use or unprotected anal intercourse (UAI). Studies 
reporting on implementation data were only included 
if performed in Europe. Systematic reviews previously 
performed on these topics were included. Non-peer-
reviewed literature was not used as a source of original 
Table 1
Highest Attainable Standard of Evidence (HASTE) system for HIV interventionsa
Grade level Strength of recommendation Explanation
Grade 1 Strong
• High plausibility
• Efficacy is consistent
• Large body of consistent implementation data
Grade 2
Grade 2a Conditional: probable
• Plausibility
• Limited efficacy data
• Consistently effective from implementation data
Grade 2b Conditional: possible
• Plausibility
• Limited or inconsistent efficacy data
• Limited or paucity of implementation datab
Grade 2c Conditional: pending • Plausibility• Ongoing efficacy trials
Grade 3 Insufficient
• Undefined plausibility
• Inconsistent data
• Inconsistent or paucity of implementation data
Grade 4 Inappropriate • Consistent data demonstrating lack of efficacy• Consensus from implementation data of inappropriate intervention
a  Modified from [21]
b  A modification has been made, adding paucity of implementation data to grade 2b.
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data, but these documents did guide further searches 
for literature. Studies published in English, French, and 
Spanish were included. Studies not fitting these crite-
ria were excluded from the review.
Electronic searches were performed in PubMed, 
Embase, Medline, Cinahl, PsycINFO, the Cochrane 
Library and the World Health Organization publication 
database. The search included medical subject head-
ings (MeSH) terms for HIV or AIDS, and terms associ-
ated with MSM and the specific interventions reviewed 
(Annex I). Searches were particularly designed to be 
broad and comprehensive initially and were performed 
between 10 December 2012 and 8 February 2013. We 
reviewed the search strategies performed between 8 
June 2010 and 17 March 2011 to guide the WHO’s 2011 
recommendations for ‘Prevention and treatment of HIV 
and other sexually transmitted infections among MSM 
and transgender people’, and where relevant these 
were updated up to 8 February 2013 [17].
Screening and data extraction
After the removal of duplicates, titles were screened 
independently by two researchers (SS, MS) to exclude 
those that did not fit the inclusion criteria. When a title 
was judged to be relevant, the abstract was reviewed 
and included if the inclusion criteria were met. When it 
was not clear whether the abstract met the inclusion 
criteria, the full article was reviewed.
For all selected  articles, data were extracted by two 
researchers (SS, MS) using a pre-designed data extrac-
tion form that included details on individual study 
design, methods of recruitment, sampling frame, 
Table 2
Number of articles found through search strategies, screened and included according to inclusion criteria for HIV 
prevention interventions among men who have sex with men in Europe
Interventions
Articles
identified
through
searches
Number of 
articles
included
addressing 
efficacy
Number of 
articles
included
addressing
implementation
Condom use 130 1 3
Universal coverage of antiretroviral treatment and treatment as prevention 9 1 4
Peer-led group interventions 326 2 0
Peer outreach 326 2 0
Voluntary HIV counselling and testing 717 2 8
Condom-compatible lubricant use (when using condoms) 130 5 2
Post-exposure prophylaxis 28 3 2
Individual counselling for MSM living with HIV 327 4 2
Peer-led group interventions targeting MSM living with HIV 326 1 2
Sex venue-based interventions 25 1 8
Social marketing interventions 476 3 7
Individual counselling for MSM 327 2 1
Internet-based HIV prevention messages 40 6 4
Training for healthcare providers to provide comprehensive care for MSM 225 0 1
MSM friendly clinics 234 0 1
Voluntary anonymous partner notification 126 0 7
Voluntary medical male circumcision 49 3 2
Pre-exposure prophylaxis 4 1 0
Campaigns for lesbian, gay, bisexual and trans equality 3 0 1
Female condom use 4 3 1
Serosorting 9 3 4
Avoid ejaculation of semen orally 226 3 0
Avoiding poppers during anal intercourse 5 0 0
Reducing alcohol binge drinking among MSM 119 1 0
Total number of articlesa 3,865 47 60
MSM: Men who have sex with men.
Searches were performed between 10 December 2012 and 8 February 2013.
a Search strategies captured the same articles to some extent.
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sample size, location, response rate, analysis per-
formed, results, confounders, reported HIV preva-
lence/incidence and self-reported sexual behaviour, 
HIV prevalence/incidence and self-reported sexual 
behaviour in comparison groups (if provided).
Analysis
First, a critical appraisal of the quality of each indi-
vidual efficacy study was performed by two research-
ers (SS, MS) using a checklist approach to assess the 
methodological components [26]. In the next step a 
compilation was done, including all relevant studies or 
reviews for each intervention. The data compilations 
were then reviewed by SS and MS, together with a sen-
ior researcher (AT), in order to check for consistency. 
Implementation studies were appraised for availability, 
acceptability, uptake, feasibility of implementation, 
implementation costs, and (when available) effective-
ness of the intervention among MSM in the European 
setting.
A paucity of implementation data was found in the EU/
EEA setting. Therefore the HASTE grading framework 
was adjusted slightly regarding grade 2b. Interventions 
with limited efficacy data, defined as being plausi-
ble but lacking European implementation data were 
assigned a grade 2b. Interventions without established 
efficacy were assigned a grade 2c in order to differen-
tiate interventions with (grade 2b) and without (grade 
2c) established efficacy.
The evidence gathered for each intervention was 
reviewed using the HASTE grading framework  [20]. 
The grading was performed independently by two 
researchers (SS and MS) and showed high agreement 
(90%). All grades were reviewed by a senior scientist 
(AT) and discrepancies were discussed initially in the 
smaller group, and following that in a conference with 
the co-authors (SS, MS, AP, FH, SB, AT) where remaining 
discrepancies and questions were resolved. Biological 
and public health plausibility was determined through 
a process of discussions within the team of co-authors.
Results
Twenty-four HIV prevention interventions for MSM were 
included and reviewed. Table 2 presents the interven-
tion topics as well as the number of articles found 
through search strategies, screened and included per 
intervention.
Interventions assigned a strong 
recommendation (HASTE grade 1)
Four interventions were assigned a HASTE grade 1: con-
dom use, universal coverage of antiretroviral treatment 
and treatment as prevention, peer-led group interven-
tions and peer outreach within the MSM community.
Condom use
Consistent efficacy data showed that condom use dur-
ing anal intercourse prevents HIV transmission. A sys-
tematic review including five cohort studies (n=8,825) 
reported that condom use reduced HIV transmission 
(relative risk (RR): 0.36; 95% confidence interval (CI) 
0.20–0.67) [27-32]. Implementation data supported 
acceptability and feasibility of condom use among 
MSM and the feasibility of condom distribution pro-
grammes in Europe [33-35]. Thirteen per cent of MSM 
in European countries reported they had UAI in the 
last 12 months solely because they did not have a con-
dom available, which points towards an unmet need 
of condoms among some MSM [36]. Plausibility was 
determined as condoms are a barrier method, thereby 
preventing the transmission of HIV. No serious poten-
tial risk with using condoms was identified.
Universal coverage of antiretroviral treatment and 
treatment as prevention
A randomised, double-blinded controlled trial with 
1,763 serodiscordant heterosexual couples and 37 
serodiscordant male MSM couples, reported a rela-
tive reduction of 96% in the number of linked HIV-1 
transmissions cases resulting from the early initiation 
of antiretroviral therapy, as compared with delayed 
therapy. Since only 37 MSM couples were included, the 
size of the relative reduction reported may not accu-
rately reflect the protective effect on sexual transmis-
sion between MSM. Implementation data reports that 
ART programmes are available in all EU/EEA countries. 
However, national treatment guidelines show diver-
sity regarding when to start treatment (at diagnosis 
or at CD4 count threshold level) [10]. Plausibility was 
deemed high as ART decreases the replication of HIV-1 
and has been shown to reduce the amount of HIV-1 in 
genital secretions [37], which is likely to be the mecha-
nism by which antiretroviral treatment reduces sexual 
transmission of the virus among MSM. However, the 
effectiveness of this intervention is dependent on com-
prehensive HIV testing programmes among MSM, and 
effective linkage to and retention in high-quality HIV 
treatment and care.
Peer-led group interventions
Peer-led group interventions, defined as interactive 
group activities where a trained peer facilitates promo-
tion of precautionary behaviours for HIV, were found 
to cause a significant reduction in UAI by a systematic 
review including 21 studies (n=5,197 and one study 
of unknown sample size) [38]. The size of the reduc-
tion ranged from 13% to 33% [38-40]. Implementation 
data show high uptake of peer-led group interven-
tions among MSM in Europe [38,41]. The intervention 
was judged plausible as the effect of peer-led group 
interventions may decrease high-risk behaviours for 
HIV through a combination of increased knowledge, 
social learning, influence of peers and normative group 
behaviour [38].
Peer-outreach
A review of systematic reviews that included 4 reviews 
(in total including 11 studies with n>7,890) found that 
peer outreach interventions, where a trained peer 
approaches MSM in community settings providing 
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Table 3a
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/inconsistent/NA Available/NA from European setting
Biological plausibility /Public 
health plausibity
HASTE 
grade 1–4
Condom use HIV incidence
Efficacy data are consistent. A 
systematic review from 2010 including 
five cohort studies (n=8,825) reports 
that the overall effect of condom 
use on HIV transmission was RR: 
0.36; 95% CI 0.20–0.67, consistent 
condom use was found to reduce HIV 
transmission by 64% [27-32].
Available. 
Distribution of 
condoms is feasible. 
High acceptability 
and feasibility of 
condom use has been 
reported among MSM 
[33-35]
The intervention has biological 
plausibility. The condom acts as 
barrier, thereby preventing the 
transmission of HIV.
No serious potential risk with 
using condoms has been 
identified. Operations research 
emphasises the importance of 
condom-compatible lubricant use 
at condom use during anal sex 
[120].
Strong, 
grade 1
Universal 
coverage of 
antiretroviral 
treatment 
and 
treatment as 
prevention
HIV 
incidence
Efficacy is consistent [37, 121-
124]. A randomised, double-
blinded controlled trial with 1,763 
serodiscordant heterosexual couples 
and 37 serodiscordant male MSM 
couples, reported a relative reduction 
of 96% in the number of linked HIV-1 
transmission cases resulting from the 
early initiation of ART, as compared 
with delayed therapy [37].
Available. 
Implementation 
data reports that 
ART programmes 
are available in all 
EU/EEA countries. 
However, national 
treatment guidelines 
show diversity 
regarding when to 
start treatment (at 
diagnosis/CD4 count 
threshold level) [10, 
121-124].
The intervention has biological 
plausibility. ART decreases 
the replication of human 
immunodeficiency virus type 1 
and has been shown to reduce 
the amount of HIV-1 in genital 
secretions [37], the likely 
mechanism for how ART reduces 
sexual transmission of the virus 
among MSM. 
A consideration is the reported 
low rates (43–84%) of ever having 
tested for HIV among European 
MSM, limiting the effect of 
serostatus-dependent prevention 
interventions [125].
Strong, 
grade 1
Peer-led 
group 
interventions
UAI
Efficacy data are consistent. A 
systematic review including 21 
studies (n=5,197 and one study 
on unknown sample size) found a 
significant reduction in UAI. The size 
of the reduction ranged from 13% to 
33% [38-40].
Available. 
Implementation data 
are consistent and 
show high uptake 
of peer-led group 
interventions [33, 38].
Peer-led group interventions 
for MSM have public health 
plausibility. Acceptability and 
uptake might be improved by the 
involvement of peers creating 
enabling and safe environments 
for MSM to provide information 
and counselling.
Strong, 
grade 1
Peer 
outreach UAI
Efficacy data are consistent. A 
systematic review including 11 studies 
(n>7,890) reports that peer-led 
outreach interventions are effective 
in reducing UAI. Three meta-analysis 
reports significant reduction in UAI 
(OR: 0.7; 95% CI 0.49–0.99; OR: 0.65; 
95% CI 0.48–0.89), RR: 0.70; 95% CI 
0.55–0.91) in comparison with no HIV 
prevention [38].
Available. Peer 
outreach is common 
and generally well-
received among MSM 
in Europe [10].
Peer outreach has public health 
plausibility through that peers 
can serve as a first point of 
interaction to create an enabling 
environment were persons 
who may not seek prevention 
interventions can be reached and 
introduced to such interventions.
Strong, 
grade 1
Voluntary 
testing and 
counselling 
for HIV
Condom 
use
Efficacy data are limited. A systematic 
review including 11 studies (n=4,416, 
of which 418 MSM), where six studies 
compared PLWH aware of their status 
with PLWH unaware of their status 
and five studies compared individuals 
before and after seroconverting. 
The data concluded that high-risk 
sexual behaviour for HIV is reduced 
after becoming aware of living with 
HIV, reduction in UAI ranged from 
25% to 65%. No reduction was seen 
among those testing negative. Among 
MSM living with HIV, studies report 
increased condom use and decrease 
in number of sexual partners 
following HIV diagnosis [42-45].
Available. 
Acceptability for 
testing was found to 
be high, EMIS reports 
that the national 
proportion of MSM 
reporting having had 
an HIV-test during 
the past 12 months 
ranged from 20% to 
47%, with a median of 
37% [35, 46-48].
The intervention has biological 
plausibility, VCT may influence 
behaviour change through a 
process involving acquisition 
of HIV/AIDS knowledge and 
learning one’s HIV serostatus 
[26]. Knowledge of HIV status 
enables access to treatment and 
prevention efforts dependent on 
HIV serostatus.
Probable, 
grade 2a
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
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Table 3b
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/inconsistent/NA Available/NA from European setting
Biological plausibility /Public 
health plausibity
HASTE grade 
1–4
Condom-
compatible 
lubricant use
Condom 
failure
Efficacy data are limited. Lack of 
additional lubricants during anal 
intercourse has been associated 
with condom failure [49-52]. A 
study investigating usage of 
915 condoms at anal intercourse 
reported a reduction in slippage 
and breakage when using lubricants 
[53]. Oil-based lubricants (not 
condom-compatible) have been 
shown to decrease tensile strength 
and increase permeability in latex 
condom and thereby increase 
breakage rates [50,51].
Available. Studies 
have showed that use 
of lubricants among 
MSM is common. 
Distribution of condom 
compatible lubricants 
is feasible [54-55]. 
The intervention has biological 
plausibility, decreasing the 
amount of condom failure as 
well as the amount of micro-
tears in rectum of the receptive 
partner by using condom-
compatible lubricants at anal 
sex might provide a protective 
effect for HIV transmission
[54-56].
Probable, grade 
2a
Post-
exposure 
prophylaxis
HIV 
incidence
Efficacy data are limited.
Two retrospective cohort studies of 
patients receiving PEP in Denmark 
(n=374) and Amsterdam (n=189) 
have been performed, each study 
reported one seroconversion [57-
58]. No adherence data was found.
Available. 
Implementation data 
reports a low demand 
for PEP in some 
European settings, the 
national proportion of 
MSM who have ever 
taken PEP ranged 
from 0% to 3.4% with 
a country median of 
1.3% [36,57-58].
The intervention has a high 
biological plausibility. ART is 
highly effective in preventing 
the HIV-1 virus to replicate, 
thereby removing any virus 
before it can establish an 
infection. However, a low 
demand has been noticed in 
some European settings, which 
might decrease the public health 
plausibility, and information and 
availability might need to be 
strengthened.
Probable, grade 
2a
Individual 
counselling 
for MSM 
living with 
HIV
UAI
Efficacy data are limited. A cohort 
study with one intervention (n=146 
MSM) and one control arm (n=180) 
reported a significant decrease 
in UAI among MSM with ≥2 sex 
partners. A study comparing 
counselling vs standard of care 
in a primary-care setting found 
no difference regarding UAI at 
six-month follow-up. A RCT of 
peer-led individual counselling 
intervention reported a decline in 
HIV transmission at 6- and 12-month 
follow-up (n=249) [59-61].
Available. 
Implementation 
data report that 
acceptability and 
uptake of individual 
counselling is high 
[60-61].
Counselling for MSM living with 
HIV has biological plausibility, 
through a process where 
increased knowledge may lead 
to behaviour change reducing 
the risk of HIV transmission and 
risk of acquiring STIs, which 
might increase viral load and 
accelerate disease progression 
[62]. The benefit of episodic 
or one-time intervention was 
subject to decay over time and it 
would need boosters to maintain 
its effect.
Probable, grade 
2a
Individual 
counselling 
for MSM
UAI
Efficacy data are inconsistent. 
A systematic review found 
inconsistent evidence regarding 
the effectiveness of counselling 
interventions in reducing UAI among 
MSM (n=11,636)  [38]. Two meta-
analysis report that HIV counselling 
(from studies with a comparison 
group receiving standard of care) 
was significantly associated with 
a reduction in UAI (OR: 0.59; 95% 
CI 0.36–0.97 n=2339; OR: 0.57; 
95% CI 0.37–0.87 n=4689) [39,40]. 
Another meta-analysis found the 
absolute effects (from studies with 
a wait list control group) to show a 
non-significant reduction in UAI (RR: 
0.80; 95% CI 0.60–1.06) [63].
Available. HIV 
counselling 
interventions are 
reported to be 
acceptable and 
feasible among MSM 
in Europe [36].
Interventions to increase 
knowledge of HIV and 
prevention measures have 
public health plausibility as they 
can influence behaviour change 
[126].
Possible, grade 
2b
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
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Table 3c
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/inconsistent/NA
Available/NA 
from European 
setting
Biological plausibility /Public 
health plausibity
HASTE 
grade 1–4
Peer-led 
group 
interventions 
targeting 
MSM living 
with HIV
UAI
Efficacy data are limited. A study 
comparing a five-session group 
intervention focusing on promoting safe 
sex (n=97) with a five-session standard 
of care support group (n=77) reports a 
decrease in UAI among participants [64]
NA
Public health plausibility was 
determined. The effect of peer-
led group interventions may 
improve uptake of intervention 
and promote safe sex behaviour 
through a combination of 
increased knowledge, social 
learning, influence of peers and 
normative group behaviour [38].
Possible, 
grade 2b
Internet-
based HIV 
prevention 
messages
UAI
Efficacy data are inconsistent. An RCT 
of a persuasive computing interactive 
intervention has shown a reduction of UAI 
at three months but could not maintain 
the effect at 12-month follow-up [65]. An 
RCT that evaluated the short-term efficacy 
(60 days) of a low intensity digital media 
intervention found significant reductions in 
UAI among men exposed to videos or to a 
website [57]. Two RCT report no differences 
in UAI between intervention and control 
groups [67-68].
NA
Interventions that increase 
knowledge on HIV and 
prevention measures have 
biological plausibility. Internet 
is one of the largest venues 
where MSM meet sexual 
partners [69,70]. Thereby 
messaging on the Internet would 
potentially reach a large number 
of MSM. In addition, safe-sex 
messaging on the venue where 
MSM meet sex partners could 
influence normative behaviour 
around safe sex.
Possible, 
grade 2b
Interventions 
in sex-on-
premises 
venues
UAI and 
uptake of 
HIV testing
Efficacy data are limited. A study 
performing a VCT intervention at a 
bathhouse tested 133 men, of whom 48% 
had not been tested in the previous 12 
months. A decrease in UAI was reported 
three months after the intervention [73-75].
NA
Sex venue-based interventions 
have public health plausibility 
through creating easy access 
to prevention interventions at 
the location where men meet 
sex partners, possibly reaching 
MSM who do not visit service 
sites [76,77]. Programmes may 
create social norms that can 
impact how MSM negotiate 
around sexual behaviour at sex 
venues [127,128] [47].
Possible, 
grade 2b
Social 
marketing 
interventions
Uptake of 
HIV-testing
Efficacy data are limited. A systematic 
review including three studies of cross-
sectional design before and after the 
intervention reports a significant increase 
in HIV-testing uptake (OR: 1.58; 95% CI 
1.40–1.77) [78].
NA
Social marketing interventions 
have public health plausibility 
through increasing knowledge 
on HIV and prevention measures 
and services. Awareness 
campaigns can also spark 
discussions and strengthen 
awareness, which can create a 
change in social norms.
Possible, 
grade 2b
Pre-exposure 
prophylaxisa
HIV 
incidence
Efficacy data are limited. One multicentre 
RCT, iPrEx, shows a 44% reduction in the 
incidence of HIV (95% CI 15–63; p=0.005) 
during a 3,324 person-years follow-up 
period among MSM. Detectable FTC–TDF 
blood levels strongly correlated with 
the prophylactic effect, emphasising the 
importance of adherence to PrEP [83].
NA
The intervention has biological 
plausibility. See section for 
PEP. Little is known about 
potential long-term side effects, 
adherence and drug resistance.
Possible, 
grade 2b
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
a New data have been published during 2015 providing implementation data for PrEP [115, 116].
b Assigned possible, grade 2b, for MSM who are only or mostly insertive during intercourse.
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Table 3D
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/
inconsistent/NA
Available/NA from 
European setting
Biological plausibility /
Public health plausibity
HASTE grade 
1–4
Voluntary 
medical male 
circumcisionb
HIV 
incidence
Efficacy data are consistent 
among men primarily or 
exclusively being insertive 
at anal sex. A Cochrane 
comprehensive review of 21 
observational studies with a 
total of 71,693 participants 
found insufficient evidence that 
male circumcision prevents 
acquisition of HIV among MSM. 
Among men having primarily or 
exclusively insertive anal sex, 
a significant decrease in HIV 
infection was found (OR:0.27; 
95% CI 0.17–0.44) [84]. A 
longitudinal study reports a 
reduced risk of HIV acquisition 
by 69% among MSM who 
reported ≥60% of acts as 
insertive with their last three 
sex partners) [85].
NA
The intervention has a 
biological plausibility 
among MSM who are only or 
mostly insertive during anal 
intercourse [85,130-133].
Possible, grade 
2b
Training for 
healthcare 
providers 
to offer 
comprehensive 
care for MSM
NA NA
NA. Many published and 
online resources are 
available to train health 
providers about issues 
facing MSM [7].
Training for providers to 
offer comprehensive care 
for MSM has public health 
plausibility. With adequate 
education and training, 
healthcare providers 
can provide appropriate 
routine care for MSM 
patients and help patients 
to avoid internalising 
stigma associated with 
homosexuality, prevent 
HIV acquisition, reduce 
unsafe sex, and lead more 
satisfying and healthy lives 
[7].
Pending, grade 
2c
MSM-competent 
clinics NA NA
Available. MSM clinics 
that offer comprehensive 
services to MSM are 
available in many European 
metropolitan areas and 
have demonstrated high 
uptake of their services 
[86].
MSM-friendly clinics 
that offer comprehensive 
services have biological 
plausibility through 
removing barriers that stop 
MSM from seeking care or 
from disclosing relevant 
personal information once in 
care [87].
Pending, grade 
2c
Voluntary 
anonymous 
partner 
notification
HIV 
incidence NA
Available. Acceptability, 
defined as willingness of 
index patients to notify 
their sex partners, has 
been shown to be high 
among MSM in Europe 
[88,89].
Contract tracing has 
biological plausibility by 
enabling early diagnosis, 
treatment and care, 
which benefits the 
individual person as well 
as likely interrupting the 
transmission chain, thereby 
reducing incidence.
Pending, grade 
2c
Campaigns 
for lesbian, 
gay, bisexual, 
transgender 
and intersex 
equality
Self-
reported 
stigma 
towards 
LGBTI
No studies have fully evaluated 
structural interventions for 
MSM. Education programmes 
focusing on changing straight-
identified persons’ perceptions 
and challenging gender 
norms have been shown to be 
successful in decreasing stigma 
[90,91].
NA
Anti-stigma and LGBTI rights 
promotion has public health 
plausibility by removing 
structural barriers and 
providing a climate where 
MSM can access preventive 
service without fear of 
stigma [134].
Pending, grade 
2c
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
a New data have been published during 2015 providing implementation data for PrEP [115, 116].
b Assigned possible, grade 2b, for MSM who are only or mostly insertive during intercourse.
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Table 3e
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/
inconsistent/NA
Available/NA 
from European 
setting
Biological plausibility /Public health 
plausibity
HASTE grade 
1–4
Female 
condom use 
at anal sex
Condom 
failure
Further evidence is needed to 
establish efficacy.
One study reports no 
significant difference regarding 
condom breakage at anal sex 
compared with male condoms, 
but a higher rate of condom 
slippage OR: 2.7; 95% CI 
1.2–5.8) (n=76) in comparison 
to male condoms [92].
NA
The intervention has biological plausibility as 
a barrier method. Female condoms potentially 
offer a protection method controlled by the 
receptive partner at anal sex. Higher rates of 
slippage, pain and discomfort when using the 
female condom at anal sex has been reported 
compared with using male latex condoms 
which is a potential risk/harm with female 
condom use at anal sex [92]. There is a need 
for safety and efficacy studies of a female 
condom designed for anal sex.
Pending, 
grade 2c
Serosorting HIV incidence
Efficacy data are inconsistent. 
A systematic review included 
three observational studies 
found that serosorting 
increased HIV transmission 
by 79% compared with 
condom use [27]. However, 
compared with no condom 
use serosorting reduced HIV 
transmission by 53% [27,93]. 
The Explore trial performed 
among MSM in six US cities 
found that serosorting was 
associated with a modest 
reduction in HIV acquisition for 
HIV-negative MSM (OR: 0.88; 
95% CI 0.81–0.95) [94].
NA. European 
men have 
reported in 
studies that they 
use serosorting 
as a risk 
management 
approach [95,96].
Serosorting may not have an effect due to 
low testing rates and the low possibility of 
detecting primary HIV infection. Public health 
plausibility is undefined, There is a risk that 
individuals may rely on a negative HIV-testing 
result that is not accurate.
Insufficient, 
grade 3
Avoiding 
semen in 
the mouth/
unprotected 
oral sex
HIV 
incidence
Efficacy data are inconsistent. 
One prospective cohort study 
including 2,189 high risk MSM 
in the US between 1992 and 
1994 (2,633 person-years) 
reports a 0.06% risk of HIV at 
receptive oral sex with a sexual 
partner living with HIV and 
a 0.04% (95% CI 0.01–0.17) 
risk with a sexual partner. A 
cross-sectional study including 
239 MSM reporting only having 
oral sex over the past six 
months (1999–2001) detected 
no cases of HIV. Observational 
studies from several high-
income country settings have 
reported cases of self-reported 
oral transmission of HIV [102, 
135-137].
NA
There is biological plausibility that not taking 
semen in the mouth and thereby limiting 
the contact between semen with possible 
HIV virus content and the oral mucosa could 
potentially remove this opportunity for 
transmission. However, transmission rates 
reported are between 0% and 0.04%, which 
is lower than estimated per contact risk 
of HIV at receptive anal intercourse with a 
condom (0.18%; 95% CI 0.10–0.28%). The 
low risk of HIV transmission implies that 
the avoidance of taking semen in the mouth 
would not have any significant effect.
Insufficient, 
grade 3
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
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information and peer support, are associated with a 
30% reduction in UAI compared with minimal or no HIV 
prevention [38]. Peer outreach is common and generally 
well-received among MSM in Europe [10]. The interven-
tion was judged plausible as peers can serve as a first 
point of interaction to create an enabling environment 
were persons who may not seek prevention interven-
tions can be reached and introduced to interventions 
such as counselling, HIV/STI testing and treatment.
Interventions assigned a probable 
recommendation (HASTE grade 2a)
HASTE grade 2a was assigned to four interventions: 
Voluntary counselling and testing for HIV, condom-
compatible lubricant, post-exposure prophylaxis (PEP), 
and individual counselling for MSM living with HIV.
Voluntary testing and counselling for HIV
A systematic review performed in 2005 including 11 
studies (n=4,416, of which 418 MSM), where six stud-
ies compared PLWH aware of their status with PLWH 
unaware of their status, and five studies compared 
individuals before and after seroconverting. The data 
concluded that high-risk sexual behaviour for HIV is 
reduced after becoming aware of living with HIV, reduc-
tion in UAI ranged from 25% to 65%, but no reduction 
was seen among those testing negative. Among MSM 
living with HIV, studies report increased condom use 
and decrease in number of sexual partners following 
HIV diagnosis and counselling [42-45].
Acceptability for testing was found to be high, EMIS 
reports that the national proportion of MSM report-
ing having had an HIV-test during the past 12 months 
ranged from 20% to 47%, with a country median of 
Table 3f
Highest Attainable Standard of Evidence (HASTE) evaluation per HIV prevention intervention in men who have sex with 
men in  Europe
Intervention Outcome
Efficacy data Implementation data Plausibility Grading
Consistent/limited/
inconsistent/NA
Available/NA 
from European 
setting
Biological plausibility /Public health plausibity HASTE grade 1–4
Avoiding nitrite 
inhalants/poppers 
at UAI
NA NA
NA. Consistent 
high usage of 
poppers across 
European 
settings was self-
reported in the 
EMIS 2010 study 
[35].
The pathway by which nitrite inhalants could 
lead to transmission of HIV is unclear. Nitrites 
inhalants cause peripheral vasodilatation and 
are believed to decrease anal sphincter tone, 
potentially leading to more traumatic sexual 
intercourse or more direct exposure to HIV target 
cells [98]. There are limited animal and human 
data suggesting that nitrite inhalants may cause 
transient immunosuppression or alter cytokine 
profiles, which could enhance transmission of 
HIV across mucosal barriers [99, 100]. Nitrite 
inhalants have been reported to be associated 
with high-risk sexual behaviour for STI/HIV 
including higher number of partners [101-103]. 
Frequent use of sex drugs may imply a high-
risk marker of behavioural disinhibition that 
includes receptive UAI with multiple partners 
[98,104]. Limited evidence supporting biological 
plausibility was found.
Insufficient, 
grade 3
Interventions to 
reduce alcohol 
binge drinking
UAI
Efficacy data are 
inconsistent. A RCT 
study evaluated a 
combined intervention 
among MSM living 
with HIV promoting 
two target behaviours, 
abstinence from/
reduction in alcohol 
use and safe sex 
practices, compared 
with an unexposed 
control group reports 
no effect on UAI 
(n=253) [105].
NA
There is plausibility that alcohol binge drinking 
through disinhibition can lead to increased 
sexual risk behaviour [138]. Thus, behavioural 
interventions that decrease alcohol consumption 
might lead to decrease in UAI.
Insufficient, 
grade 3
ART: antiretroviral therapy; CI: confidence interval; EEA: European Economic Area; EMIS: European MSM Internet survey; EU: European Union; 
FTC–TDF: emtricitabine and tenofovir ; LGBTI: lesbian, gay, bisexual, transgender and intersex; MSM: men who have sex with men; NA: not 
available; OR: odds ratio; PEP: post-exposure prophylaxis; PrEP: pre-exposure prophylaxis; PLWH: people living with HIV; RCT: randomised 
controlled trial; RR: relative risk; UAI: unprotected anal intercourse; US: United States; VCT: voluntary testing and counselling.
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37%. However, the proportion that were ‘quite’ or 
‘very’ confident they could access an HIV test if they 
wanted one ranged from 73% to 96% with a median 
of 91% [35,46-48]. Plausibility was determined as VCT 
may influence behaviour through a process involving 
acquisition of HIV/AIDS knowledge and learning one’s 
HIV serostatus [45]. In addition, knowledge of HIV sta-
tus enables access to ART and care, reducing onward 
transmission.
Condom-compatible lubricant use
Lack of additional lubricants during anal intercourse 
has been associated with condom failure [49-52]. A 
study investigating usage of 915 condoms at anal inter-
course reported a reduction in slippage and breakage 
when using lubricants [53]. However, oil-based lubri-
cants (not condom-compatible) have been shown to 
decrease tensile strength and increase permeability 
in latex condom and increase breakage rates [50,51]. 
Implementation data reports that lubricant use among 
MSM is high [36]. The intervention was judged plausi-
ble by the decrease in condom failure as well as that 
the amount of micro-tears in rectum of the receptive 
partner may be diminished by using condom-compat-
ible lubricants [54-56].
Post-exposure prophylaxis
PEP, defined as the administration of ART starting 
within 72 hours post exposure and prolonged for 28 
days, was evaluated by two retrospective cohort stud-
ies of patients receiving PEP in Denmark (n=374) and 
Amsterdam (n=189), each study reported one sero-
conversion [57,58]. No adherence data were found. 
Implementation data reports a low demand for PEP in 
some European settings, although it is considered the 
standard of care. The national proportion of MSM who 
have ever taken PEP ranged from 0% to 3.4% with a 
country median of 1.3% [36]. Low demand and uptake 
limit the public health impact of PEP. Information about 
and availability of PEP might need to be strengthened 
[57,58]. Plausibility is determined by the effect of ART 
post-exposure (within 72 hours) that diminishes the 
HIV-virus before an infection can be established.
Individual counselling for men who have sex with men 
living with HIV
A cohort study comparing an intervention group receiv-
ing individual counselling on risk reduction for HIV by 
a trained counsellor (n=146) and one control group 
(n=180) reported a significant decrease in UAI among 
MSM living with HIV with more than two sexual part-
ners. Another RCT of peer-led individual counselling 
intervention reported a decline in sexual risk behav-
iour for HIV at 6 and 12 months follow-up (n=249) 
[59-61]. Implementation data report that acceptability 
and uptake of individual counselling are high [60,61]. 
Plausibility is determined through a process where 
increased knowledge may lead to behaviour change 
reducing the risk of HIV transmission and risk of acquir-
ing STIs that might increase viral load and accelerate 
disease progression [62].
Interventions assigned a possible 
recommendation (HASTE grade 2b)
An additional seven interventions were graded HASTE 
grade 2b including: individual counselling for MSM, 
peer-led group interventions targeting MSM living with 
HIV, Internet-based HIV prevention messages, inter-
ventions in sex-on-premises venues, social marketing 
interventions, pre-exposure prophylaxis (PrEP) and 
voluntary medical male circumcision.
Individual counselling for men who have sex with men
Two meta-analyses examining individual counselling 
on HIV risk reduction with a comparison group receiv-
ing standard care found significant 41% and 43% reduc-
tions in UAI (OR: 0.59; 95% CI 0.36–0.97, n=2,339; OR: 
0.57; 95% CI 0.37–0.87, n=4,689) [39,40]. A recent 
systematic review which included both these studies 
reports inconsistent evidence regarding the effective-
ness of individual counselling in reducing UAI among 
MSM (n=11,636) [38]. This is due to the inclusion of 
another meta-analysis that found individual counsel-
ling clients (compared with waiting list control group) 
to report a non-significant 20% reduction in UAI (RR: 
0.80; 95% CI 0.60–1.06) [63]. HIV counselling interven-
tions are reported to be acceptable and feasible among 
MSM in Europe [36]. Plausibility is defined as interven-
tions that increase knowledge of HIV and prevention 
measures can influence behaviour change.
Peer-led group interventions targeting men who have 
sex with men living with HIV
Peer-led group interventions among MSM living with 
HIV are defined as interactive group activities facili-
tated by a trained peer. A study comparing a five-ses-
sion group intervention focusing on promoting safe 
sex (n=97) with a five-session standard of care support 
group (n=77) reports a decrease in UAI among partici-
pants [64]. Implementation data were not available. 
Plausibility was determined as the effect of peer-led 
group interventions may improve uptake by creating 
enabling and safe environments for MSM and promote 
safe sex behaviour through a combination of increased 
knowledge, social learning, influence of peers and nor-
mative group behaviour [38].
Internet-based HIV prevention messages
The Internet is a special venue in the sense that apart 
from being another potential meeting-dating venue, it 
may also be a venue for private and anonymous access 
to sexual health and well-being, at your own choice of 
time and physical place. Since specific longitudinal 
online interventions exist that are exclusively for use 
on the Internet, it was deemed important to review 
Internet-based interventions separately from other 
sex-venue based interventions.
An RCT of a persuasive computing interactive HIV 
messaging intervention has shown a reduction of UAI 
at three-month follow-up, but could not maintain the 
effect at 12-month follow-up [65]. An RCT that evalu-
ated the short-term efficacy (60 days) of a low-intensity 
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digital media HIV messaging intervention found sig-
nificant reductions in UAI among men exposed to 
videos or to a website [66]. Two RCTs report no differ-
ences in UAI between an intervention group receiving 
Internet-based messaging and non-exposed control 
groups [67,68]. The Internet is a common setting for 
MSM to meet sexual partners [69-72]. Messaging on 
the Internet would potentially reach a large number of 
MSM. The intervention was judged plausible as safe 
sex messaging on the online venue where MSM meet 
sex partners could influence normative behaviour 
around safer sex practices.
Interventions in sex-on-premises venues
Interventions in sex-on-premises venues are defined as 
prevention activities such as information, counselling 
and VCT at venues where MSM gather and seek sexual 
partners. A VCT intervention at a bathhouse tested 133 
men of whom 48% had not been tested in the previous 
12 months. A decrease in UAI was reported 3 months 
after the intervention, which highlights the prevention 
effect of HIV testing among those never tested before 
[73-75]. Implementation data were not available. Sex 
venue-based interventions have public health plausi-
bility through creating easy access to prevention inter-
ventions at a location where MSM gather and meet sex 
partners, possibly reaching MSM who do not visit ser-
vice sites [76,77].
Social marketing interventions
A systematic review of social marketing strategies 
promoting HIV testing (including three intervention 
evaluations of cross-sectional before-and-after design) 
reports a significant increase in HIV-testing uptake 
(OR: 1.58; 95% CI 1.40–1.77) [78]. Social marketing 
interventions include media messaging (any form of 
media) grounded in social marketing theory [79-82]. 
Implementation data were not available. Public health 
plausibility is achieved through increasing knowledge 
of HIV and prevention measures and services, through 
manipulation of perceptions of the desirability of pre-
cautions (and the undesirability of risks) and through 
the promotion of social norms for precaution.
Pre-exposure prophylaxis
One multicentre RCT, iPrEx, evaluated the efficacy of 
once-daily oral emtricitabine and tenofovir (FTC–TDF, 
Truvada) among men and transgender women who 
have sex with men (n=1,251) compared with placebo 
(n=1,224) for the prevention of HIV acquisition. One 
hundred people became infected during the follow-up 
period of 1.8 years (median, 1.2 years; maximum, 2.8 
years, total of 3,324 person-years). Thirty six in the 
FTC–TDF group and 64 in the placebo group became 
infected, which indicates a 44% reduction in the inci-
dence of HIV (95% CI 15–63; p=0.005). In the FTC–TDF 
group, the study drug was detected in 22 of 43 of 
seronegative subjects (51%) and in 3 of 34 HIV-infected 
subjects (9%) (p<0.001) [83]. Detectable FTC–TDF 
blood levels strongly correlated with the prophylactic 
effect, emphasising the importance of adherence to 
PreP. Little is known about potential long-term side 
effects, adherence, impact on other risk behaviour and 
drug resistance. Biological plausibility is determined; 
ART is highly effective in preventing replication of the 
HIV-1 virus, and so its presence could remove any virus 
before an infection can be established.
Voluntary medical male circumcision
A Cochrane comprehensive review of 21 observational 
studies with a total of 71,693 participants found insuf-
ficient evidence that male circumcision prevents acqui-
sition of HIV among MSM [84]. However, among men 
having primarily or exclusively insertive anal sex, there 
was a significant decrease in HIV infection (OR: 0.27; 
95% CI 0.17–0.44) [84]. The longitudinal study sug-
gested that it reduced risk of HIV acquisition by 69% 
among MSM who reported ≥60% of acts as insertive 
with their last three partners [85]. Programmatic issues 
such as safety of male circumcision, sexual behaviour 
following male circumcision, and sexual satisfaction 
and function have not been addressed specifically 
among MSM. No implementation data were found. The 
effect is plausible among MSM who are only or mostly 
insertive during anal intercourse, which would com-
prise a limited group of MSM. Therefore, the interven-
tion receives a grade of 2b for MSM who are only or 
mostly insertive during anal intercourse.
Interventions assigned a pending 
recommendation (HASTE grade 2c)
A HASTE grade 2c was assigned to five interventions: 
training for healthcare providers to offer comprehen-
sive care for MSM, MSM-competent health clinics, vol-
untary anonymous partner notification, campaigns for 
lesbian, gay, bisexual, transgender and intersex equal-
ity (LGBTI), and female condom use for anal intercourse.
Training for healthcare providers to offer 
comprehensive care for men who have sex with men
Published and online resources are available to train 
health providers about issues facing MSM, but no 
evaluation study was found [7]. Implementation data 
were not available. Plausibility was deemed strong 
because training providers can offer comprehensive 
care for MSM, including appropriate routine care for 
MSM patients, and help patients to avoid internalis-
ing stigma associated with homosexuality, prevent HIV 
and other STI acquisition, and lead more satisfying and 
healthy lives [7].
MSM-competent health clinics
MSM-competent health clinics that offer comprehen-
sive services to MSM are available in many European 
metropolitan areas and have demonstrated high 
uptake of their services [86]. MSM-competent health 
clinics that offer comprehensive services have plau-
sibility through removing barriers that prevent MSM 
from seeking care or from disclosing relevant personal 
information once in care [87].
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Voluntary anonymous partner notification
No studies evaluating voluntary anonymous part-
ner notification were found. Acceptability, defined as 
willingness of index patients to notify their sex part-
ners about living with HIV, has been shown to be high 
among MSM in Europe [88,89]. Voluntary anonymous 
partner notification has a plausible effect by enabling 
early diagnosis, treatment and care, which benefits the 
individual person as well likely interrupting the trans-
mission chain, thereby reducing HIV incidence.
Campaigns for lesbian, gay, bisexual, transgender and 
intersex equality
No studies have fully evaluated structural interven-
tions for MSM defined as activities promoting equality 
through education, media awareness campaigns and 
policy regarding an HIV-preventative effect. Education 
programmes focusing on changing straight-identified 
men and women’s perceptions of the heterosexual 
majority and challenging gender norms have been 
shown to be successful in decreasing stigma against 
LGBTI [90,91]. Implementation data are not available. 
Anti-stigma and LGBTI rights promotion have public 
health plausibility by removing structural barriers and 
providing a climate where MSM can access preventive 
and care service without fear of stigma.
Female condom use for anal intercourse
In comparisons with male condoms, one study reports 
the female condom to have no significantly different 
breakage at anal intercourse, but to have a higher 
rate of slippage OR: 2.7; 95% CI 1.2–5.8 (n=76) [92] 
No implementation data from Europe were found. The 
intervention has plausibility as a barrier method for 
HIV transmission. Female condoms potentially offer 
a protection method controlled by the receptive part-
ner at anal intercourse. Higher rates of slippage, pain 
and discomfort when using the female condom at anal 
intercourse have been reported compared with using 
male latex condoms, which is a potential risk/harm 
with female condom use at anal intercourse [92]. There 
is a need for safety and efficacy studies of a female 
condom developed particularly for anal intercourse.
Interventions assigned an insufficient 
recommendation (HASTE grade 3)
An insufficient level of evidence available, HASTE 
grade 3, was assigned to four interventions: serosort-
ing, avoiding taking semen in the mouth/unprotected 
oral sex, avoiding use of poppers at UAI and avoiding 
alcohol binge drinking.
Serosorting
A systematic review including three observational 
studies [27] found that serosorting (i.e. only engaging 
in unprotected intercourse with individuals thought to 
have the same HIV status), increased HIV transmission 
by 79% compared with condom use. However, com-
pared with no condom use, serosorting reduced HIV 
transmission by 53% [27, 93]. The Explore trial per-
formed among MSM in six cities in the United States 
(US) found that serosorting was associated with a mod-
est reduction in HIV acquisition for HIV-negative MSM 
(OR: 0.88; 95% CI 0.81–0.95) [94]. Some European men 
have reported in studies that they use serosorting as a 
risk management approach [95, 96]. Serosorting may 
not have an effect due to low testing rates and the low 
possibility of detecting primary HIV infection. There is 
a risk that individuals may rely on a negative HIV test 
result that is not accurate. Serosorting among people 
living with HIV can be associated with an increased 
risk of STIs, which have been shown to cause a peak 
in HIV viral load in semen among individuals on ART, 
which could affect HIV onward transmission [97]. Public 
health plausibility is undefined.
Avoiding semen in the mouth/unprotected oral sex
A prospective cohort study including 2,189 high-risk 
MSM in the US between 1992 and 1994 (2,633 person 
years) reported a 0.06% risk of HIV at receptive oral sex 
with a sexual partner living with HIV and a 0.04% (95% 
CI 0.01–0.17) risk with a sexual partner of unknown 
serostatus [102]. A cross-sectional study including 239 
MSM reporting only oral sex over the past six months 
(1999–2001) detected no HIV. No implementation data 
are available [136].
There is biological plausibility that not taking semen 
in the mouth and thereby limiting the contact between 
semen with possible HIV virus content and the oral 
mucosa could potentially remove this opportunity for 
transmission. However, transmission rates reported 
are between 0% and 0.04%, which is lower than esti-
mated per contact risk of HIV at receptive anal inter-
course with a condom (0.18%; 95% CI 0.10–0.28) The 
low risk of transmission implies that the avoidance of 
taking semen in the mouth would not have a significant 
effect on transmission [11].
Avoiding use of nitrite inhalants/poppers at unprotected 
anal intercourse
No efficacy data were available. Consistent high usage 
of poppers across European settings was self-reported 
in the EMIS 2010 study [36]. The pathway by which 
nitrite inhalants could lead to transmission of HIV 
transmission is unclear. Nitrite inhalants cause periph-
eral vasodilatation and are believed to decrease anal 
sphincter tone, potentially leading to more traumatic 
sexual intercourse or more direct exposure to HIV tar-
get cells [98]. There are limited animal and human data 
suggesting that nitrite inhalants may cause transient 
immunosuppression or alter cytokine profiles, which 
could enhance transmission of HIV across mucosal bar-
riers [99,100]. Nitrite inhalants have been reported to 
be associated with high-risk sexual behaviour for STI/
HIV including higher number of partners [101-103]. 
Frequent use of sex drugs may imply a high-risk marker 
of behavioural disinhibition that includes unprotected 
receptive anal intercourse with multiple partners 
[98,104]. Thereby, there is limited evidence supporting 
biological plausibility.
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Interventions to reduce alcohol binge drinking
An RCT evaluated a combined intervention among 
MSM living with HIV promoting two target behaviours, 
abstinence from/reduction in alcohol use and safe sex 
practices, compared with an unexposed control group 
(n=253). The intervention had no effect on UAI [105]. 
Implementation data were not available. There is plau-
sibility that alcohol binge drinking may cause disinhi-
bition that can lead to increased sexual risk behaviour. 
Thus, behavioural interventions that decrease alcohol 
consumption might lead to a decrease in UAI.
Discussion
This systematic review of HIV prevention interventions 
among MSM found that four of the 24 interventions 
reviewed could be assigned a HASTE grade 1, equal to 
a strong recommendation. Another four interventions 
could be assigned grade 2a, equal to a probable rec-
ommendation. In addition, another seven interventions 
were assigned grade 2b, a possible recommendation. 
Unambiguous recommendations can be made to MSM 
to use condoms and condom-compatible lubricant when 
engaging in anal intercourse, to test frequently for HIV 
and STIs, to use ART if living with HIV, and, if unin-
fected, to use PEP if exposed to HIV. Recommendations 
can be made to service commissioners and providers 
to provide MSM with access to HIV testing, to provide 
medical care including ART to PLWH, to provide PEP to 
those not infected, and to provide or make otherwise 
accessible condoms and lubricant. Interventions which 
promote HIV testing, condom use, ART and PEP can 
also be recommended. Evidence-based delivery modes 
include peer-led interventions, educational outreach 
and group work programmes, with specific peer-led 
programmes for men living with HIV.
An important consideration in HIV prevention pro-
gramme planning is that there are synergies and 
dependency between the recommended interven-
tions, indicating that combining interventions into pro-
grammes is desirable [106]. For example, biomedical 
interventions dependent on HIV serostatus (e.g. ART, 
PrEP, PEP) need to be implemented in combination with 
easy access to the provision of VCT. An HIV-testing ser-
vice itself can achieve high coverage through peer out-
reach and social marketing. Therefore, interventions 
should be packaged together to enhance their poten-
tial full effect to prevent HIV.
There was a striking lack of European effectiveness 
studies, where interventions are examined outside an 
RCT setting. Additional research into the areas of effec-
tiveness in the European context is needed inform HIV 
prevention decision-making and programme planning. 
These are required both regarding new interventions, 
such as the implementation of PrEP programmes, and 
to report results of follow-up on already-implemented 
interventions such as early initiation of ART, PEP, and 
voluntary anonymous partner notification.
The challenge of scaling up ART for MSM with HIV in 
Europe includes both more widespread and more fre-
quent HIV-testing, as well as increasing ART accessibil-
ity to men testing positive. In 2013, 37% of the MSM 
diagnosed with HIV in the EU/EEA were diagnosed 
late (defined as CD4 cell count <350/μL), indicating 
that many men who acquire HIV are unaware of their 
infection for some time [107]. Models using data from 
the 2010 United Kingdom national cohort of MSM liv-
ing with HIV suggest that extending ART to MSM diag-
nosed with HIV with CD4 counts <500 cells/μL would 
have reduced the overall proportion of infectious men 
from 35% to 29%. However reducing the undiagnosed 
population by 50% would have reduced this to 21%, 
which serves to emphasise the importance of frequent 
HIV testing [108].
Comprehensive community education programmes 
linking peer community outreach work with easy 
access to HIV-testing and treatment are key compo-
nents of universal coverage of antiretroviral treatment 
and treatment as prevention. As HIV self-tests become 
authorised for use in European countries, they may 
contribute to increased testing and linkage to care. A 
French study reported that accessing an unauthorised 
HIV self-test was associated with living one’s sex life 
with men in total secrecy and having had unprotected 
anal intercourse with men during the last 12 months, 
indicating that for particular groups of MSM, autono-
mous self-testing may reduce barriers to testing [109]. 
The majority of literature on VCT included in this review 
was published before 2000, indicating a need for more 
contemporary published studies evaluating delivery of 
HIV testing among MSM in Europe.
Drug approval by the European Medicines Agency for 
emtricitabine and tenofovir disoproxil fumarate (TDF/
FTC), brand-named Truvada, to be used for pre-expo-
sure prophylaxis is currently pending. It has been 
approved by the US Food and Drug Administration 
since July 2012. Studies among MSM in France and the 
UK have showed a high interest in and acceptability for 
PreP among MSM [110,111]. Half of 842 HIV-negative 
MSM in London reported that they would consider using 
PrEP if it became available as a daily pill [111]. The long-
term health effects of TDF/FTC in HIV-uninfected men 
and men who become HIV-infected while taking PrEP 
needs evaluation [112-114]. The PROUD clinical trial 
in the UK and the IPERGAY clinical trial in France and 
Canada report that PrEP is highly protective against 
HIV acquisition among HIV-negative MSM and that 
PrEP use was not associated with increased number of 
sexual partners, decreased condom use, or increased 
incidence of STIs [115,116]. PROUD and IPERGAY data 
were not available when this review was performed but 
should be taken into account when providing guidance 
on PrEP.
In Europe, structural barriers including human rights 
violations, homophobia, direct and indirect discrimi-
nation and obstructive policies and laws all limit the 
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effectiveness of HIV intervention programmes, by 
reducing service uptake and by compromising the qual-
ity of services. In the European Survey of Lesbian, Gay, 
Bisexual and Transgender persons conducted in 2012, 
38% of European MSM respondents said that they 
were not open with any healthcare provider about their 
sexual orientation; the percentage of men saying this 
was 70% or higher in several EU countries, including 
Lithuania, Slovakia, Romania, Poland, and Latvia [117]. 
Structural interventions aiming to decrease stigma and 
discrimination against MSM could result in an open 
climate where MSM feel safe to disclose their sexual 
practice and enrol in prevention and treatment pro-
grammes. Evaluation research is needed to guide how 
structural interventions for MSM in Europe would best 
be designed and implemented. As LGBTI rights improve 
in diverse European settings there will be opportuni-
ties for evaluating the health impacts that might be 
achieved due to structural and policy changes, and 
these should not be missed.
More descriptive data are needed on morbidity, well-
being and health service use among MSM and MSM 
sub-populations. To minimise selection  bias inherent 
in sampling strategies such as purposive or voluntary 
recruitment, combinations of sampling strategies that 
complement each other may increase validity. These 
may include the inclusion of sexual identity and prac-
tice variables in service monitoring, respondent driven 
sampling in real-life or on the web and time-location 
sampling.
This systematic review of HIV prevention interventions 
among MSM aimed for a comprehensive evidence-
based multidisciplinary approach. The HASTE grading 
framework that is designed to evaluate HIV interven-
tions among MSM allowed for an inclusive approach 
employing three tiers of data, and was particularly 
helpful for highlighting the importance of implemen-
tation data. In the grading process, we spent time 
thoroughly discussing the differences between HASTE 
grade 2a probable, 2b possible and 2c pending for rec-
ommendation. These grades overlap somewhat, and 
careful consideration is required when assigning them.
Behavioural and biological outcomes were assigned 
the same value according to the inclusion criteria for 
this review. As HIV incidence studies are rare, this 
review argues that all available efficacy data are rel-
evant to include if the specific outcome variables are 
transparently reported. Reliance on self-reports of 
sexual risk behaviour is however subject to recall bias 
and social desirability bias, which may have diluted 
the measured effects of some interventions [118]. Most 
studies applied a short recall duration, which has been 
shown to maximise self-report accuracy and thereby 
diminish recall bias [119].
In this review it was notable that studies usually 
evaluated a mix of different (often related or entan-
gled) interventions rather than a single component 
intervention. Similarly, outcome data in intervention 
studies are usually combined without disaggregating 
results by, for example, knowledge of partners’ HIV 
status. Hence the effects of different individual compo-
nents as well as effects in MSM sub-groups might be 
diluted in some results.
Serosorting was assigned an insufficient grade of 
recommendation and is not to be considered as a HIV 
intervention that should be recommended for MSM. 
However, many MSM in Europe use this tactic and so 
communication around serosorting, including the risk 
of HIV transmission and acquisition as well as STI 
acquisition, is important to address in counselling and 
information to MSM.
Encouragingly, fifteen interventions were graded to be 
strongly, probably or possibly recommended. These 
interventions can complement each other to maxim-
ise their impact and to address prevention needs and 
preferences of a diverse population of MSM. Offering 
and implementing prevention packages in collabora-
tion with community members is crucial to the success 
of national and sub-national prevention programmes 
in the EU/EEA. In the relatively resource-rich European 
setting, there is an opportunity to provide global lead-
ership with regard to the regional scale-up of com-
prehensive effective HIV prevention interventions for 
MSM.
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